title: Haemolytic uraemic syndrome following chemotherapy for an unusual germ-cell tumour.
authors.affiliation: Renal Unit, St. James's University Hospital, Leeds, UK.
authors.forename: R V
authors.initials: RV
authors.lastname: Mathur
authors.forename: S
authors.initials: S
authors.lastname: Kumar
authors.forename: S
authors.initials: S
authors.lastname: Aparicio
authors.forename: P W
authors.initials: PW
authors.lastname: Johnson
authors.forename: C G
authors.initials: CG
authors.lastname: Newstead
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects; D002945:Cisplatin / Q000009:adverse effects; D018240:Endodermal Sinus Tumor / Q000150:complications / Q000188:drug therapy*; D005047:Etoposide / Q000009:adverse effects; D018238:Gonadoblastoma / Q000150:complications / Q000188:drug therapy*; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D006869:Hydronephrosis / Q000150:complications; D008297:Male; D006435:Renal Dialysis; D013736:Testicular Neoplasms / Q000150:complications / Q000188:drug therapy*
chemical_list: D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin